CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy

Cancer immunotherapy has gained attention as the supreme therapeutic modality for the treatment of various malignancies. Adoptive T-cell therapy (ACT) is one of the most distinctive modalities of this therapeu...

Source: Journal of Experimental and Clinical Cancer Research - August 26, 2021 Category: Cancer & Oncology Authors: Sasan Ghaffari, Nastaran Khalili and Nima Rezaei Tags: Review Source Type: research